Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact and Prevalence of PAD on Cancer Patients at High-risk for PAD Going to Surgery

NCT05754944 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT05754944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05754944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact and Prevalence of PAD on Cancer Patients at High-risk for PAD Going to Surgery
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
February 22, 2023
Completion date
February 28, 2027
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease (pad) in cancer patients